
Bioliberty
Bioliberty develops soft-robotic systems and AI-powered digital therapy platforms for upper-extremity recovery in patients with neurological conditions or injuries.
About
Bioliberty is a rehabilitation technology startup that develops soft-robotic systems for upper-extremity recovery in patients suffering from strokes or neurological conditions. Its product suite includes Lifehub, a portable control center that powers the system and delivers interactive therapy sessions; Lifeglov, a soft robotic wearable glove that assists patients in opening and strengthening their hands; and Lifemind, a clinician-facing dashboard that centralizes therapy data and uses AI to auto-generate clinical notes.
Key facts
- Website
- bioliberty.com
- Headquarters
- Edinburgh, United Kingdom
- Founded
- 2020
- Total funding
- $3M (Series A Extension)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Nov 2026 | Series A Extension | $3M |
Tech stack
Detected on bioliberty.com, last scanned 6 Nov 2026. Run your own scan
- Support
- HubSpot
- CDN
- Cloudflare
- Email provider
- Microsoft 365
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is Bioliberty trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Bioliberty is 85 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Bioliberty raised?
Bioliberty has raised a total of $3M in funding. The most recent round on record is Series A Extension.
SEC filings, insider activity, nonprofit links and pay benchmarks for Bioliberty:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules


